Showing results (1301-1310 of 6,769) with videos related to

Sort By:
Pageof 677
Clinical Therapeutics|September 1, 1989
A multicenter comparison of adhesion, preference, tolerability, and safety characteristics of two transdermal nitroglycerin delivery systems: Transderm-Nitro and DeponitD A Chinoy, J Camp, S Elchahal, et al.
Clinical Therapeutics|November 5, 2013
A randomized, double-blind, placebo-controlled, parallel-group study to evaluate the efficacy and safety of the extended-release tramadol hydrochloride/acetaminophen fixed-dose combination tablet for the treatment of chronic low back painJae Hyup Lee, Chong-Suh Lee,
Clinical Therapeutics|July 15, 2014
Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftarolineGeorge Sakoulas, Pamela A Moise, Anthony M Casapao, et al.
Clinical Therapeutics|March 30, 2016
The Alarmin Properties of DNA and DNA-associated Nuclear ProteinsMelinda Magna, David S Pisetsky
Clinical Therapeutics|March 30, 2016
Single-dose Pharmacokinetic Properties and Relative Bioavailability of a Novel Methylphenidate Extended-release Chewable Tablet Compared With Immediate-release Methylphenidate Chewable TabletRichat Abbas, Donna Palumbo, Faith Walters, et al.
Clinical Therapeutics|March 30, 2016
Efficacy and Safety of Belimumab Plus Standard Therapy in Patients With Systemic Lupus Erythematosus: A Meta-analysisLi-Qiang Wei, Yong-Gang Liang, Yong Zhao, et al.
Clinical Therapeutics|March 30, 2016
Efficacy and Safety of the SGLT2 Inhibitor Luseogliflozin in Japanese Patients With Type 2 Diabetes Mellitus Stratified According to Baseline Body Mass Index: Pooled Analysis of Data From 52-Week Phase III TrialsSoichi Sakai, Kohei Kaku, Yutaka Seino, et al.
Clinical Therapeutics|March 30, 2016
Multi-indication Pharmacotherapeutic Multicriteria Decision Analytic Model for the Comparative Formulary Inclusion of Proton Pump Inhibitors in QatarDaoud Al-Badriyeh, Ibrahim Alabbadi, Michael Fahey, et al.
Clinical Therapeutics|April 5, 2016
Pitavastatin versus Pravastatin in Reduction of Remnant Lipoprotein Cholesterol in Patients with DyslipidemiasLeonardo Roever
Clinical Therapeutics|April 5, 2016
Qualitative Development and Content Validity of the Non-small Cell Lung Cancer Symptom Assessment Questionnaire (NSCLC-SAQ), A Patient-reported Outcome InstrumentKelly P McCarrier, Thomas M Atkinson, Kendra P A DeBusk, et al.
Pageof 677